| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Antigenic Specificity | PD-L1 |
|---|
| Clone | monoclonal |
|---|
| Host Species | Human |
|---|
| Reactive Species | human |
|---|
| Isotype | IgG1 |
|---|
| Format | affinity purified |
|---|
| Size | 100 μg |
|---|
| Concentration | n/a |
|---|
| Applications | Neutralization, ELISA |
|---|
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
|---|
| Description | Monoclonal human IgG1 antibody against human PD-L1. Atezolizumab (Tecentriq) is a fully humanized, engineered monoclonal antibody of IgG1 isotype against the protein programmed cell death-ligand 1 (PD-L1). Atezolizumab blocks the interaction of PD-L1 with PD-1 and induces anti-tumor immune reactivation. |
|---|
| Immunogen | Human programmed cell death 1 ligand 1 (PD-L1) |
|---|
| Other Names | Tecentriq, PD-L1 |
|---|
| Gene, Accession # | Gene ID: 29126, Accession: Q9NZQ7 |
|---|
| Catalog # | A1305-100 |
|---|
| Price | |
|---|
| Order / More Info | PD-L1 Antibody from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|